hand holds the floating brain

Evidence Based, Research Validated

LUCID’s technology is rooted in prior research on the effects of music on health outcomes. In addition to this, we pursue rigorous scientific validation trials alongside experts and accredited institutions to understand the safety and efficacy of our music technology on these outcomes.
Contact Us

A Growing Body of Research

Read our literature bank of relevant studies and publications on music's impact in health.
LUCID
Comparison of LUCID's Digital Music Therapy, Generic Functional Music and Self-Selected Music
Read now
LUCID
Music as Medicine: LUCID Science + Technology White Paper
Read now
Drs. Frank Russo & Adiel Mallik, Ryerson University Dept. of Psychology
The Effect of Music & Auditory Beat Stimulation on Anxiety
Read now

Our Research Partners

woman is lying in the laboratory

A New Approach to Anxiety

In our Adult Acute Anxiety Study, a single 24-minute listening session produced more significant reductions in somatic and cognitive anxiety, compared to pink noise or auditory beat stimulation.

LUCID’s music technology has also indicated a greater ability to reduce stress and boost positive mood, as compared to the top relaxation playlist on a major music streaming platform.

To participate in our clinical trial, please click here to learn more.

woman in black sweater is putting on white headphones

Elevating Music Beyond Entertainment

Nearly 20% of the population in North America is affected by an anxiety disorder, making it the single most common mental health challenge. The good news? Over 60% of people use music to target stress and anxiety in their daily lives (compared to 10% who turn to meditation and 7% who use therapy).

In addition to being an effortless daily practice that most of us love, listening to music can dial back the body’s stress response by increasing parasympathetic nervous system activity and decreasing sympathetic nervous system activity. This shift implies a change from responsiveness/reactivity to stress, to a state of active recovery.

Anxiety is only the beginning. With positive clinical results, we are working to expand the applications of our music technology to help people facing a variety of mental and neuropsychiatric health challenges.
chain of DNA

Rooted in scientific evidence, meticulously tested

Our digital music therapy technology is designed around the iso principle, a method used in music therapy in which music is selected that meets the listener where they are by matching their initial mood, then gradually shifts to induce the desired mood. This is shown to be more effective in helping the listener get to their desired mental and emotional state.​

We measure our users' mood in real time using proprietary psychometric and biometric tools. Our machine learning algorithms then use this information to create personalized music sequences, optimized for each user’s specific journey.

LUCID goes beyond generic functional music by measuring our users’ mood and personalizing their music experience in real-time.
About our music

Our Experts

Our highest priority is to help people effectively manage and maintain their emotional wellbeing using a tool they know and love: music. We are proud to work with leading researchers to conduct rigorous studies, thus setting a high bar for our technology’s performance.

Dr. Frank Russo

Chief Science Officer
As Chief Science Officer, Dr. Frank A. Russo, Ph.D. leads LUCID's efforts to broaden and adapt its Digital Music Therapy technology into new therapeutic domains. Dr. Russo is Professor of Psychology and the NSERC-Sonova Senior Industrial Research Chair in Auditory Cognitive Neuroscience at Ryerson University. He is also Status Professor of Speech Language Pathology and Music, University of Toronto; Affiliate Research Scientist at Toronto Rehabilitation Institute; and Research Affiliate at McMaster Institute for Music and the Mind. At Ryerson's SMART Lab, Russo conducts research on the biological, cognitive, and social-emotional bases of music and speech. He is a Fellow of the Canadian Psychological Association and Massey College, and is a past president of the Canadian Acoustical Association. He currently serves as Associate Editor (Frontiers in Emotion Science; Music Perception); and is Past Editor-in-Chief (Canadian Acoustics).

Dr. Sageev Oore

Head of Machine Learning
As LUCID’s Head of Machine Learning, Dr. Sageev Oore advises on the application of artificial intelligence into the field of music for therapeutic outcomes. Dr. Sageev Oore is the Canada CIFAR AI Chair and a Research Faculty Member at the Vector Institute. He is an associate professor of Computer Science at Dalhousie University, where his research interests include machine learning and deep learning, with an emphasis on music, audio processing & creative applications. Dr. Oore was a Visiting Research Scientist at Google Brain, working on the Magenta Project and developing generative music systems such as PerformanceRNN. He is also an award-winning musician, studying piano performance with music teachers from Dalhousie, Juilliard, and UBC.

Dr. Rebecca Kleinberger

Voice Technology Expert, MIT
Dr. Rebecca Kleinberger is a voice expert and a researcher at the McGovern Institute/Media Lab at MIT. Her work spans from assistive technologies to vocal experiences design. Her research connects various fields, including sensor technologies, wearable computing, design, HCI, neurology, clinical research, and psychology. Kleinberger has developed unique expertise in the study, analysis, and understanding of the human voice. Her research aspiration is to create more healthy and meaningful technologies with and for the voice. She received a Masters in Media Arts and Sciences from MIT, a Masters in Virtual Environment and Computer Graphics from UCL in London, and a Masters in Mechanical Engineering from ENSAM Paris.

Dan McClure

Finance & Investments Advisor
Dan McClure is a financial industry veteran, spending over 20 years in the capital markets, and has executive experience in media.  He is currently Co-founder and Principal at Blue Deer Capital and previously was the president of Bron Studios.
He previously served as Head of Research at I.G. Investment Management, a $100B+ asset manager, and CEO & CIO of alternative manager, CQI Capital Management. As a portfolio manager, Mr. McClure managed over $3 billion of private and public assets. He has designed and launched four separate investment funds and is an active angel investor.

Dr. Farooq Naeem

Psychiatry Advisor, Chief of General and Health Systems Psychiatry CAMH
Dr. Farooq Naeem is the Chief of General and Health Systems Psychiatry at CAMH and professor of Psychiatry at the University of Toronto.
He has pioneered techniques for culturally adapting CBT. These techniques have been used to adapt CBT for a variety of common and severe mental health problems in South Asia, North Africa, the Middle East and China. He is considered a leader in global mental health.

Beverly Dywan

Experience Design Consultant
Beverly Dywan is a design consultant, and educator at OCAD University in Industrial Design and Inclusive Design. She also serves on the University’s Senate. Additionally, she has been a consultant to the Toronto Rehab Institute, providing a window onto their research and innovation.
Beverly has extensive international experience working with cultural institutions. Her company Design in Three Dimensions has provided experience and exhibit design, as well as strategic planning work for museums in Canada, the United States, and Hong Kong.